IN8BIO, INC. — Form D
IN8BIO, INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-15. The offering totals $12.4M, of which $12.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-15
- Form: D
- Accession: 0001231919-24-000084
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $12.4M
- Amount sold: $12.4M
- Investors: 73
- Date of first sale: 2024-10-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-526844
Issuer
- Name: IN8BIO, INC.
- CIK: 0001740279
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: EMPIRE STATE BUILDING, NEW YORK, NY, 10118
- Phone: (646) 600-6438
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Travis R Whitfill | Director | New York, NY |
| Luba R Greenwood | Director | New York, NY |
| Lawrence R Lamb | Executive Officer | New York, NY |
| William Ho | Director | New York, NY |
| William Ho | Executive Officer | New York, NY |
| Jeremy R Graff | Director | New York, NY |
| Kate R Rochlin | Executive Officer | New York, NY |
| Emily R Fairbairn | Director | New York, NY |
| Corinne R Epperly | Director | New York, NY |
| Alan S Roemer | Director | New York, NY |
| Patrick McCall | Executive Officer | New York, NY |
| Emily S Fairbairn | Director | New York, NY |
| Trishna R Goswami | Executive Officer | New York, NY |
| Travis Whitfill | Director | Hummelstown, PA |
| Melissa Beelen | Executive Officer | New York, NY |
| Thomas Cirrito | Director | New York, NY |
| Larry Lamb | Executive Officer | New York, NY |
| Peter Brandt | Director | New York, NY |
| Peter S Brandt | Director | Colorado Springs, CO |
Other filings by this issuer (5)
More